Today's Research Reports on Trending Tickers: Paratek Pharmaceuticals and Trevena
NEW YORK, NY / ACCESSWIRE / October 3, 2018 / Wall Street closed mostly lower on Tuesday with the Dow Jones posting its fourth consecutive daily gain, however broader market dropped over trade related concerns. The Dow Jones Industrial Average gained 0.46 percent to close at 26,773.94, its 14th record close for 2018 fueled by gains in Intel Corp and Caterpillar Inc. The S&P 500 Index shed 0.04 percent to close at 2,923.43, while the Nasdaq Composite Index dropped 0.47 percent to close at 7,999.55.
“U.S. stocks are mixed with the global markets looking past yesterday’s trade agreement with Canada, as the U.S./China relationship remains contentious,” said Charles Schwab analysts. “Records in the U.S. stock market do not, in our view, mean that investors should get more aggressive in their investment stance. High expectations, elevated investor sentiment, trade disputes, and the possibility of a monetary mistake lead us to take a more cautious stance,” said the analysts.
RDI Initiates Coverage on:
Paratek Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=PRTK
Trevena, Inc.
https://rdinvesting.com/news/?ticker=TRVN
Paratek Pharmaceuticals' stock moved 5.04% lower Tuesday, to close the day at $9.24. The stock recorded a trading volume of 1,563,481 shares, which was above its three months average volume of 529,903 shares. In the last year, Paratek Pharmaceuticals' shares have traded in a range of 9.00 - 26.10. The share price has gained 2.67% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $9.84 is below its 200-day moving average of $10.90. Shares of Paratek Pharmaceuticals have fallen roughly 9.85 percent in the past month and are down 48.38 percent year-to-date.
Access RDI's Paratek Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=PRTK
On Tuesday, shares of Trevena recorded a trading volume of 8,295,886 shares, which was above the three months average volume of 1,654,543 shares. The stock ended the day 13.19% higher at $2.66. The share price has fallen 0.37% from its 52 week high with a 52 week trading range of 1.34 - 2.67. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $1.73 is above its 200-day moving average of $1.70. Shares of Trevena have gained roughly 47.78 percent in the past month and are up 66.25 percent year-to-date.
Access RDI's Trevena, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=TRVN
Our Actionable Research on Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) and Trevena, Inc. (NASDAQ:TRVN) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
